COVID-19 Vaccine Acceptance and Access Among Black and Latinx Communities.
Journal
JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235
Informations de publication
Date de publication:
01 10 2021
01 10 2021
Historique:
entrez:
13
10
2021
pubmed:
14
10
2021
medline:
26
10
2021
Statut:
epublish
Résumé
Black and Latinx communities have faced disproportionate harm from the COVID-19 pandemic. Increasing COVID-19 vaccine acceptance and access has the potential to mitigate mortality and morbidity from COVID-19 for all communities, including those most impacted by the pandemic. To investigate and understand factors associated with facilitating and obstructing COVID-19 vaccine access and acceptance among Black and Latinx communities. This community-partnered qualitative study conducted semistructured, in-depth focus groups with Black and Latinx participants from March 17 to March 29, 2021, using a secure video conferencing platform. Participants were recruited through emails from local community-based organizations, federally qualified health centers, social service agencies, the New Haven, Connecticut, Health Department, and in-person distribution of study information from community health workers. A total of 8 focus groups were conducted, including 4 in Spanish and 4 in English, with 72 participants from a diverse range of community roles, including teachers, custodial service workers, and health care employees, in New Haven, Connecticut. Data were analyzed from March 17 to July 30, 2021. Interviews were audio-recorded, transcribed, translated, and analyzed using an inductive content analysis approach. Themes and subthemes were identified on the acceptability and accessibility of the COVID-19 vaccine among participants who identified as Black and/or Latinx. Among 72 participants, 36 (50%) identified as Black, 28 (39%) as Latinx, and 8 (11%) as Black and Latinx and 56 (78%) identified as women and 16 (22%) identified as men. Participants described 3 major themes that may represent facilitators and barriers to COVID-19 vaccinations: pervasive mistreatment of Black and Latinx communities and associated distrust; informing trust via trusted messengers and messages, choice, social support, and diversity; and addressing structural barriers to vaccination access. The findings of this qualitative study may impact what health care systems, public health officials, policy makers, health care practitioners, and community leaders can do to facilitate equitable uptake of the COVID-19 vaccine. Community-informed insights are imperative to facilitating COVID-19 vaccine access and acceptance among communities hardest hit by the pandemic. Preventing the further widening of inequities and addressing structural barriers to vaccination access are vital to protecting all communities, especially Black and Latinx individuals who have experienced disproportionate death and loss from COVID-19.
Identifiants
pubmed: 34643719
pii: 2784917
doi: 10.1001/jamanetworkopen.2021.28575
pmc: PMC8515205
doi:
Substances chimiques
COVID-19 Vaccines
0
Types de publication
Journal Article
Research Support, U.S. Gov't, P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2128575Subventions
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States
Commentaires et corrections
Type : CommentIn
Références
Am J Prev Med. 2009 May;36(5):379-84
pubmed: 19211213
BMC Med Ethics. 2017 Mar 1;18(1):19
pubmed: 28249596
JAMA Intern Med. 2021 Feb 1;181(2):157-158
pubmed: 33284328
Qual Health Res. 2005 Nov;15(9):1277-88
pubmed: 16204405
Am J Prev Med. 2021 May;60(5):621-628
pubmed: 33745817
MMWR Morb Mortal Wkly Rep. 2021 Jul 16;70(28):985-990
pubmed: 34264911
JAMA. 2020 Nov 24;324(20):2027-2028
pubmed: 33064145
JAMA. 2021 Jul 27;326(4):301-302
pubmed: 34232270
JMIR Mhealth Uhealth. 2020 Sep 21;8(9):e20356
pubmed: 32955455
Am J Public Health. 2015 Dec;105(12):e60-76
pubmed: 26469668
Prev Chronic Dis. 2010 May;7(3):A67
pubmed: 20394706
N Engl J Med. 2020 Sep 17;383(12):e77
pubmed: 32706952
JAMA Netw Open. 2021 Jul 1;4(7):e2117074
pubmed: 34264327
J Med Internet Res. 2020 Jun 11;22(6):e16002
pubmed: 32525482
Health Educ Res. 2009 Feb;24(1):42-8
pubmed: 18203679
Pediatrics. 2020 Jul;146(1):
pubmed: 32540984
Clin Infect Dis. 2021 Feb 09;:
pubmed: 33560346
Matern Child Health J. 2020 Apr;24(4):456-461
pubmed: 31893386
Oncol Nurs Forum. 2014 Sep;41(5):545-7
pubmed: 25158659
Vaccine. 2020 Oct 14;38(44):6941-6953
pubmed: 32943266
Eur J Intern Med. 2021 May;87:106-108
pubmed: 33810941
Glob Health J. 2021 Mar;5(1):51-55
pubmed: 33585053
Health Secur. 2021 Mar-Apr;19(2):223-228
pubmed: 33346721
J Am Geriatr Soc. 2021 Apr;69(4):888-891
pubmed: 33555042
JAMA Intern Med. 2021 Jul 1;181(7):1008-1011
pubmed: 33783471
J Health Care Poor Underserved. 2020;31(4):1515-1519
pubmed: 33416732
JAMA. 2021 Mar 2;325(9):829-830
pubmed: 33512381
N Engl J Med. 2021 Jul 8;385(2):97
pubmed: 33789007
Ethn Health. 2009 Feb;14(1):75-91
pubmed: 19152160
MMWR Morb Mortal Wkly Rep. 2021 Feb 05;70(5):174-177
pubmed: 33539333
JAMA Netw Open. 2021 Mar 1;4(3):e215344
pubmed: 33755164